Company profile: Bausch Health
1.1 - Company Overview
Company description
- Provider of specialty pharmaceuticals and aesthetic medical devices, developing and marketing treatments across gastrointestinal and hepatologic, dermatology (acne, psoriasis, actinic keratosis, atopic dermatitis), neurology, infectious diseases, oral health (adult periodontitis, mouth dryness), and generics. Divisions include Salix Pharmaceuticals, Ortho Dermatologics, Solta Medical, International Pharmaceuticals (500+ products), and OraPharma.
Products and services
- Ortho Dermatologics: Develops and markets clinical-grade dermatology products for actinic keratosis, acne, atopic dermatitis, and psoriasis, targeting specific dermatologic conditions with indicated therapies
- Salix Pharmaceuticals: Licenses, develops, and markets pharmaceutical-grade therapeutics to treat gastrointestinal and hepatologic conditions, constructing a specialized portfolio focused on digestive and liver disease management
- International Pharmaceuticals: Offers a diverse, global-scale portfolio of over 500 products across Europe, Middle East, Africa, CIS, Latin America, Canada, and Asia Pacific
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bausch Health
Norgine
HQ: The Netherlands
Website
- Description: Provider of specialist pharmaceuticals with direct commercial presence in major European markets and infrastructure to develop, manufacture and commercialise therapies, including MOVICOL for chronic constipation; MOVIPREP and PLENVU for colon cleansing before colonoscopy; XIFAXAN for hepatic encephalopathy; FERACCRU for iron deficiency anemia; and LYMPHOSEEK for lymphatic mapping and sentinel lymph node biopsy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Norgine company profile →
Techlab
HQ: United States
Website
- Description: Provider of intestinal diagnostics products, including patented QUIK CHEK rapid tests delivering extremely accurate results in 30 minutes; founded in 1989, headquartered in Blacksburg, VA, with a state-of-the-art manufacturing facility in Radford, VA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Techlab company profile →
Vigilant Biosciences
HQ: United States
Website
- Description: Provider of early cancer detection solutions focused on oral cancer, offering the BeVigilant OraFusion System that uses specific biomarkers to deliver semi-quantitative risk results (low, moderate, elevated), along with clinician resources for dental practices on diagnosis and treatment and patient education materials on risks, symptoms, and the importance of early detection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vigilant Biosciences company profile →
ErgoNordic
HQ: Sweden
Website
- Description: Provider of health care products, engaged in development, import and marketing, operating as a subsidiary of Mediplast.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ErgoNordic company profile →
Venaxis
HQ: United States
Website
- Description: Provider of in vitro diagnostics, focused on developing and commercializing a unique multi-biomarker diagnostic; based in Colorado.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Venaxis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bausch Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bausch Health
2.2 - Growth funds investing in similar companies to Bausch Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bausch Health
4.2 - Public trading comparable groups for Bausch Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →